Literatur
-
1
Schmidt S, Fischer T W, Chren M M, Strauss B M, Elsner P.
Strategies of coping and quality of life in women with
alopecia.
Br J Dermatol.
2001;
144
1038-1043
-
2
Fischer T W, Schmidt S, Strauss B, Elsner P.
Hairdex – ein Instrument zur Untersuchung der
krankheitsbezogenen Lebensqualität bei Patienten mit
Haarerkrankungen.
Hautarzt.
2001;
52
219-227
-
3
Hoffmann R, Happle R.
Current understanding of androgenetic alopecia. Part I:
etiopathogenesis.
Eur J Dermatol.
2000;
10
319-327
-
4
Kaufman K D.
Androgen metabolism as it affects hair growth in androgenetic
alopecia.
Dermatol Clin.
1996;
14
697-711
-
5
Paus R, Cotsarelis G.
The biology of hair follicles.
N Engl J Med.
1999;
341
491-497
-
6
Rebora A.
Pathogenesis of androgenetic alopecia.
J Am Acad Dermatol.
2004;
50
777-779
-
7
Trueb R M.
Molecular mechanisms of androgenetic alopecia.
Exp Gerontol.
2002;
37
981-990
-
8
Foitzik K, Paus R.
Regulation of human hair growth and therapeutic options.
Journal of the German Society of Dermatology.
2005;
3
901-915
-
9 Fischer T W, Paus R. Androgenetic Alopecia. In: Encyclopedia of Molecular Mechanisms of Disease. Berlin; Springer 2006
-
10
Hamilton J B.
Patterned loss of hair in man: types and incidence.
Ann N Y Acad Sci.
1951;
53
708-728
-
11
Norwood O T.
Male-pattern baldness. Classification and incidence.
South Med J.
1975;
68
1359-1370
-
12
Ludwig E.
Classification of the types of androgenetic alopecia (common
baldness) occurring in the female sex.
Br J Dermatol.
1977;
97
247-254
-
13 Wolff H, Kunte C. Diagnostik und Therapie von Haarerkrankungen, Vol. 1. Bremen; Uni-Med 1999
-
14
Bergner T, Braun-Falco O.
Die androgenetische Alopezie der Frau.
Hautarzt.
1991;
42
201-210
-
15
Schweikert H U, Wilson J D.
Regulation of human hair growth by steroid hormones. I.
Testerone metabolism in isolated hairs.
J Clin Endocrinol Metab.
1974;
38
811-819
-
16
Kaufman K D, Olsen E A, Whiting D, Savin R, De Villez R, Bergfeld W, Price V H, Van Neste D, Roberts J L, Hordinsky M, Shapiro J, Binkowitz B, Gormley G J.
Finasteride in the treatment of men with androgenetic
alopecia. Finasteride male pattern hair loss study group.
J Am Acad Dermatol.
1998;
39
578-589
-
17
Jacobs J P, Szpunar C A, Warner M L.
Use of topical minoxidil therapy for androgenetic alopecia in
women.
Int J Dermatol.
1993;
32
758-762
-
18
Olsen E A, Dunlap F E, Funicella T, Koperski J A, Swinehart J M, Tschen E H, Trancik R J.
A randomized clinical trial of 5 % topical
minoxidil versus 2 % topical minoxidil and placebo in the
treatment of androgenetic alopecia in men.
J Am Acad Dermatol.
2002;
47
377-385
-
19
Whiting D A, Jacobson C.
Treatment of female androgenetic alopecia with minoxidil
2 %.
Int J Dermatol.
1992;
31
800-804
-
20
Lucky A W, Piacquadio D J, Ditre C M, Dunlap F, Kantor I, Pandya A G, Savin R C, Tharp M D.
A randomized, placebo-controlled trial of 5 %
and 2 % topical minoxidil solutions in the treatment of female
pattern hair loss.
J Am Acad Dermatol.
2004;
50
541-553
-
21
Olsen E A, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B.
A multicenter, randomized, placebo-controlled, double-blind
clinical trial of a novel formulation of 5 % minoxidil topical
foam versus placebo in the treatment of androgenetic alopecia in men.
J Am Acad Dermatol.
2007;
57
767-774
-
22
Freyschmidt-Paul P.
Alopecia areata.
CME Dermatologie.
2007;
3
4-14
-
23
Tosti A, Iorizzo M, Botta G L, Milani M.
Efficacy and safety of a new clobetasol propionate
0.05 % foam in alopecia areata: a randomized, double-blind
placebo-controlled trial.
J Eur Acad Dermatol Venereol.
2006;
20
1243-1247
-
24
Fischer T W.
Haarausfall bei internmedizinischen Erkrankungen.
Therapeutische Umschau.
2002;
59
238-242
-
25
Hendrix S, Handjiski B, Peters E M, Paus R.
A guide to assessing damage response pathways of the hair
follicle: lessons from cyclophosphamide-induced alopecia in mice.
J Invest Dermatol.
2005;
125
42-51
-
26 Schell H. Erkrankungen der Haare, Vol. 1. Stuttgart, Berlin, Köln; W. Kohlhammer 1997
-
27
Fischer T, Köhler L D, Vogt H-J.
Haarveränderungen durch Krankheit oder Medikamente.
Hautnah Dermatologie.
2000;
5
7-11
-
28
Graham-Little E.
Folliculitis decalvans et atrophicans.
Proc Roy Soc Med.
1915;
8
139-140
-
29
Kossard S.
Postmenopausal frontal fibrosing alopecia. Scarring alopecia
in a pattern distribution.
Arch Dermatol.
1994;
130
770-774
-
30
Moreno-Ramirez D, Camacho Martinez F.
Frontal fibrosing alopecia: a survey in 16 patients.
J Eur Acad Dermatol Venereol.
2005;
19
700-705
-
31
Kossard S, Lee M S, Wilkinson B.
Postmenopausal frontal fibrosing alopecia: a frontal variant
of lichen planopilaris.
J Am Acad Dermatol.
1997;
36
59-66
-
32
Tosti A, Piraccini B M, Iorizzo M, Misciali C.
Frontal fibrosing alopecia in postmenopausal women.
J Am Acad Dermatol.
2005;
52
55-60
-
33
Zinkernagel M S, Trueb R M.
Fibrosing alopecia in a pattern distribution: patterned
lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction
pattern?.
Arch Dermatol.
2000;
136
205-211
-
34
Wilson C L, Burge S M, Dean D, Dawber R P.
Scarring alopecia in discoid lupus erythematosus.
Br J Dermatol.
1992;
126
307-314
-
35
Hermes B, Paus R.
„Vernarbende” Alopezien – Anmerkungen zur
Klassifikation, Differenzialdiagnose und Pathobiologie.
Hautarzt.
1998;
49
462-472
-
36
Braun-Falco O, Bergner T, Heilgemeir G P.
The Brocq pseudopelade – a disease picture or disease
entity.
Hautarzt.
1989;
40
77-83
-
37
Paquet P, Pierard G E.
Dapsone treatment of folliculitis decalvans.
Ann Dermatol Venereol.
2004;
131
195-197
-
38
Abeck D, Korting H C, Braun-Falco O.
Folliculitis decalvans. Long-lasting response to combined
therapy with fusidic acid and zinc.
Acta Derm Venereol.
1992;
72
143-145
-
39
Brooke R C, Griffiths C E.
Folliculitis decalvans.
Clin Exp Dermatol.
2001;
26
120-122
-
40
Powell J, Dawber R P.
Successful treatment regime for folliculitis decalvans
despite uncertainty of all aetiological factors.
Br J Dermatol.
2001;
144
428-429
-
41
Brocq L.
Des folliculites et perifolliculites decalvantes.
Bull Mem Soc Med Hop Paris.
1988;
5
399-408
-
42
Price V H, Gummer C L.
Loose anagen syndrome.
J Am Acad Dermatol.
1989;
20
249-256
-
43
Hamm H, Traupe H.
Loose anagen hair of childhood: The phenomenon of easily
pluckable hair.
J Am Acad Dermatol.
1989;
20
242-248
-
44
Tosti A, Peluso A M, Misciali C, Venturo N, Patrizi A, Fanti P A.
Loose anagen hair.
Arch Dermatol.
1997;
133
1089-1093
-
45
Antaya R J, Sideridou E, Olsen E A.
Short anagen syndrome.
J Am Acad Dermatol.
2005;
53
130-134
-
46
Barraud-Klenovsek M M, Trueb R M.
Congenital hypotrichosis due to short anagen.
Br J Dermatol.
2000;
143
612-617
-
47
Van Egmond S, Hoedemaker C, Sinclair R.
Short anagen hair naevus: improvement after treatment with
5 % topical minoxidil.
Int J Dermatol.
2007;
46
757-759
-
48
Hoffmann R.
TrichoScan: combining epiluminescence microscopy with digital
image analysis for the measurement of hair growth in vivo.
Eur J Dermatol.
2001;
11
362-368
-
49
Hoffmann R.
TrichoScan, a GCP-validated tool to measure hair growth.
J Eur Acad Dermatol Venereol.
2008;
22
132-134; author reply 134 – 135
Dr. med. Tobias W. Fischer
Klinik für Dermatologie, Allergologie und
Venerologie
Universitätsklinikum
Schleswig-Holstein
Universität zu Lübeck
Ratzeburger Allee 160
23538 Lübeck
Email: Tobias.Fischer@uk-sh.de
